Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia will be in London, UK for the 9th Digital Pathology and AI Congress 7-8 December 2022, where the focus of this year’s event is utilizing AI & digital pathology to advance pathology practice, enable enhanced patient care and further drug discovery.

Visit us at Booth #1 for live product demos where you can see first-hand how we support diagnostic labs and life sciences teams with Concentriq®, our AI-ready software platform powering the modern pathology lab. Meet with our experts and take the next step on your digital and computational pathology journey.

Computational Pathology and AI Session

Real-world learnings from the deployment of digital and computational pathology at scale: The Unilabs Story

Unilabs is one of Europe’s leading diagnostics companies, offering a complete range of laboratory, pathology and imaging services to patients across four continents. Join Dr. Rahul Chaudhary and Dr. Thomas Sollie as they relate their first-hand experiences as pathologists deploying and integrating AI into diagnostic processes. Dr. Chaudhary will share the Unilabs story, and their vision of becoming the most digitally-driven diagnostic group. Dr. Sollie will then share the results of the recent study on the potential impact of Proscia’s DermAI on the laboratory’s high-throughput pathology operations and decreased turnaround times that could enable patients to start treatment sooner.

Day 2, Thursday, December 8th | 12:55–1:25 PM BST

Corey Chivers, PhD
Senior AI Scientist, Proscia

Contributing Authors: Julianna Ianni, Sean Grullon, Vaughn Spurrier, Yang Jiang, Jiayi Zhao

Scientific Poster Presentation

Using AI to Understand the Sources of Diagnostic Discordance in Melanocytic Lesions

The digitization of pathology workflows has opened up the potential for enormous benefit from the use of AI to drive diagnostic assistance and workflow optimization. AI models, however, rely not only on high quality images, but also on high quality labels. In many diagnostic domains, there is a high discordance rate among pathologists resulting in uncertain labels with which to build AI models. This study uses an AI model of benign vs suspected malignant melanocytic lesions to disentangle inter-pathologist discordance into its two distinct components of bias and noise, and explore the unique impact of each on AI model development.

Poster Space #15

We’ve curated the resources below for you and your team to learn more about Proscia, our products and solutions.

Brochures & White Papers

News, Articles & Blogs

Virtual Events & Webinars

Watch a panel discussion and Q&A with Proscia and thought leaders from our customers LabPON and Unilabs, along with AI partners Visiopharm and Ibex Medical Analytics. The focus of this pre-ECP discussion is on market trends among early adopters of AI in the European market, real-world experiences integrating AI within the digital pathology workflow and key decision-making considerations for successful implementations.

Watch on-demandLink Arrow

Hear from our customer LabPON as they share insights and key results from testing the interoperability of Proscia’s Concentriq® Dx digital pathology software platform and the IBEX GalenTM Platform.

Watch on-demandLink Arrow

This virtual event brings together researchers, scientists and digital pathology pioneers to accelerate life sciences research; includes a keynote with Dr. Scott Gottlieb, former FDA Commissioner, and breakout sessions with Bristol Myers Squibb, Charles River Labs, Google and Visiopharm.

Watch on-demandLink Arrow

Take The Next Step

If you'd like to learn more about Proscia's digital and computational pathology solutions, contact us or register for a demo of Concentriq.

Our website uses cookies. By using this site, you agree to its use of cookies.